← All trials
NCT00343161
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2006
- Primary completion
- Aug 1, 2007
- Completion date
- Aug 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 441
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- AstraZenecaLead sponsor
- Evan. Jung-Stilling-Krankenhaus, Siegen, GermanyOverall official - principal investigator
- AstraZenecaStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.